VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 81.07% | 40.48% | 10.21% | 24.19% | 16.75% |
| Total Depreciation and Amortization | 0.91% | -1.75% | -4.35% | -12.50% | -9.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,414.04% | -74.48% | 307.46% | 270.04% | -86.38% |
| Change in Net Operating Assets | -115.44% | 1,500.00% | 32.04% | 53.78% | 160.19% |
| Cash from Operations | 16.51% | 86.28% | 50.83% | 66.37% | 29.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 113.36% | -101.47% | -91.11% | -- | -- |
| Total Debt Repaid | -3.06% | -3.06% | -3.06% | 56.34% | 0.00% |
| Issuance of Common Stock | -84.54% | -99.77% | -- | 19.41% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.56% | 16.42% | 100.00% | -- | -- |
| Cash from Financing | -16.43% | -114.88% | -60.54% | 1,883.47% | 2,438.89% |
| Foreign Exchange rate Adjustments | 93.87% | -245.61% | 741.18% | 103.77% | -393.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.02% | 8.33% | -48.13% | 129.84% | 95.17% |